1. A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro
- Author
-
Henry Querfurth, John Marshall, Keykavous Parang, Mengia S. Rioult-Pedotti, Rakesh Tiwari, Bumsup Kwon, Steve Reisinger, and Han-Kyu Lee
- Subjects
Physiology ,Alzheimer's Disease ,Toxicology ,Pathology and Laboratory Medicine ,Biochemistry ,Rats, Sprague-Dawley ,Mice ,Endocrinology ,Medical Conditions ,Antibiotics ,Medicine and Health Sciences ,Insulin ,Post-Translational Modification ,Phosphorylation ,Materials ,Neurons ,Multidisciplinary ,Antimicrobials ,Drugs ,Neurodegenerative Diseases ,Neurology ,Doxycycline ,Physical Sciences ,Medicine ,Signal Transduction ,Research Article ,Science ,Materials Science ,Microbiology ,3-Phosphoinositide-Dependent Protein Kinases ,Antimalarials ,Allosteric Regulation ,Alzheimer Disease ,Cell Line, Tumor ,Microbial Control ,Mental Health and Psychiatry ,Animals ,Humans ,Pentanoic Acids ,Diabetic Endocrinology ,Pharmacology ,Amyloid beta-Peptides ,Endocrine Physiology ,Toxicity ,Insulin Signaling ,Biology and Life Sciences ,Proteins ,Hormones ,Rats ,Oligomers ,Dementia ,Insulin Resistance - Abstract
The Alzheimer’s brain is affected by multiple pathophysiological processes, which include a unique, organ-specific form of insulin resistance that begins early in its course. An additional complexity arises from the four-fold risk of Alzheimer’s Disease (AD) in type 2 diabetics, however there is no definitive proof of causation. Several strategies to improve brain insulin signaling have been proposed and some have been clinically tested. We report findings on a small allosteric molecule that reverses several indices of insulin insensitivity in both cell culture andin vitromodels of AD that emphasize the intracellular accumulation of β-amyloid (Aβi). PS48, a chlorophenyl pentenoic acid, is an allosteric activator of PDK-1, which is an Akt-kinase in the insulin/PI3K pathway. PS48 was active at 10 nM to 1 μM in restoring normal insulin-dependent Akt activation and in mitigating Aβi peptide toxicity. Synaptic plasticity (LTP) in prefrontal cortical slices from normal rat exposed to Aβ oligomers also benefited from PS48. During these experiments, neither overstimulation of PI3K/Akt signaling nor toxic effects on cells was observed. Another neurotoxicity model producing insulin insensitivity, utilizing palmitic acid, also responded to PS48 treatment, thus validating the target and indicating that its therapeutic potential may extend outside of β-amyloid reliance. The describedin vitroandcell based-in vitrocoupled enzymatic assay systems proved suitable platforms to screen a preliminary library of new analogs.
- Published
- 2022
- Full Text
- View/download PDF